METAPRO

METAPRO is designed for companies and brands operating in the health supplement, functional nutrition, and metabolic health markets. Its primary target buyers include dietary supplement brands, wellness and weight management brands, pharmaceutical-adjacent nutraceutical companies, and OEM/ODM partners seeking differentiated metabolic health solutions.
The product is particularly relevant for buyers focusing on obesity management, blood sugar regulation, liver fat metabolism, gut health, and immune support, where GLP-1–related mechanisms are gaining global attention.
Additionally, METAPRO is suitable for premium consumer health brands looking to offer an all-in-one daily supplement that combines metabiotics, probiotics, and multivitamins in a convenient format.
Given its patented technology and scientifically validated positioning, METAPRO is well aligned with buyers targeting clinically inspired, evidence-based, and premium health supplement segments, especially in markets where GLP-1–related metabolic solutions are expanding rapidly.

METAPRO is intended for daily, routine consumption as part of a comprehensive health and metabolic care regimen. It can be consumed anytime and anywhere, without water, thanks to its stick-type powder format.
Typical usage scenes include morning health routines, before or after exercise, during work or travel, and on-the-go lifestyle situations where convenience is essential.
It is positioned for individuals managing weight control, appetite balance, blood sugar regulation, gut health, and overall nutritional intake. METAPRO supports these needs by promoting GLP-1 secretion, maintaining gut microbiome balance, and providing essential daily vitamins in a single product.
The product eliminates the inconvenience of taking multiple supplements separately, making it suitable for busy professionals, health-conscious consumers, and individuals seeking simple but comprehensive daily health solutions.

METAPRO’s core sales point lies in its patented GLP-1–promoting metabiotics technology based on Lactiplantibacillus plantarum OPT-A1. In vitro studies demonstrated a 331% increase in GLP-1 secretion compared to control intestinal cells.
The product integrates three key functions in one formula: metabolic balance through GLP-1 activation, gut health support with high-concentration probiotics (10 billion CFU), and nutritional balance via multivitamins meeting 80–180% of daily recommended intake.
Unlike conventional probiotics, METAPRO uses acid-resistant metabiotics, ensuring functional stability through the digestive tract.
Backed by registered Korean patents and OPTBIO’s proprietary R&D, METAPRO offers buyers a scientifically validated, premium, and differentiated solution in the competitive metabolic health supplement market.

JAPAN ： Both direct and indirect transactions are acceptable

CANADA ： Both direct and indirect transactions are acceptable